FDA concerns about unapproved GLP-1 drugs used for weight loss
In westernized societies, acne vulgaris is a nearly universal skin disease afflicting 79% to 95% of teens
Here we overview the glucose-lowering and weight-reducing effects of incretin-based therapies, discussing the effective and safety use of DPP-4 inhibitors, GLP-1 RAs, and GIP/GLP-1 receptor agonist tripeptide in Japanese individuals with type 2 diabetes
Lai YH, Lee MC, Ho GJ, et al
31, 2026 Good deal of synergy brewing in South Osborne Gabrielle Pich 5 minute read Preview Good deal of synergy brewing in South Osborne Gabrielle Pich 5 minute read Friday, Jul
This is when patients are getting cheaper medications off the Internet from compounding pharmacies, where the labeling can be confusing